MMP12 and triple-A syndrome: The findings presented here provide strong evidence demonstrating the deleterious role of aberrant MMP-12 activity in AAA development, alongside providing proof-of-concept evidence to motivate translational work upon MMP-12 inhibitor therapy in humans.